Literature DB >> 18804097

Population-based association study and contrasting linkage disequilibrium pattern reveal genetic association of SLC6A4 with autism in the Indian population from West Bengal.

Subhrangshu Guhathakurta1, Swagata Sinha, Saurabh Ghosh, Anindita Chatterjee, Shabina Ahmed, Prasanta Kumar Gangopadhyay, Rajamma Usha.   

Abstract

Serotoninergic dysfunction is highly implicated in autism. Serotonin transporter gene (SLC6A4) that regulates synaptic serotonin level has been investigated as a candidate gene for autism, but consensus opinion on possible association is still lacking. Converging evidences of platelet-hyperserotoninemia in approximately 25% of the patients, betterment of ritualistic behavior on administration of SSRI and linkage to chromosome 17q11 harboring SLC6A4, supports the hypothesis that SLC6A4 polymorphisms may contribute towards autism pathology. Our recent report on 5-HTTLPR marker represents the first study on genetic association of SLC6A4 with autism in the Indian population. Further analysis involving additional markers may reinforce the earlier hypothesis. So in the present study, we have investigated the association of a VNTR of 17 bp at intron2 (STin2) and an SNP at 3'UTR (HTT-3'UTR-SNP) of the gene with autism using family and population-based approaches. We have genotyped 421 individuals (93 autistic subjects, their parents and 160 controls) and consistent with other publications, family-based association studies using individual markers (STin2 and HTT-3'UTR-SNP) have not revealed any preferential allelic transmission to the probands. However, the interesting finding of strong linkage disequilibrium (LD) between the markers and significant disease-specific distortion in the distribution of HTT-3'UTR-SNP genotypes (T1chi(2)=5.19, P=0.02; OR=2.89, 95% CI=1.13-7.41) and the specific haplotypes of the two markers (LRS=11.85, p(c)=0.02), with higher frequencies of T/T genotype and 10-T haplotype in autistic cases suggests that either these markers or nearby markers of SLC6A4 that are in LD, may pose a risk towards autism in the Eastern Indian population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804097     DOI: 10.1016/j.brainres.2008.08.063

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Early event-related potentials to emotional faces differ for adults with autism spectrum disorder and by serotonin transporter genotype.

Authors:  Susan Faja; Geraldine Dawson; Elizabeth Aylward; Ellen M Wijsman; Sara Jane Webb
Journal:  Clin Neurophysiol       Date:  2016-03-19       Impact factor: 3.708

2.  Parent-of-origin effects of the serotonin transporter gene associated with autism.

Authors:  Emily Kistner-Griffin; Camille W Brune; Lea K Davis; James S Sutcliffe; Nancy J Cox; Edwin H Cook
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-12-08       Impact factor: 3.568

Review 3.  Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder.

Authors:  Valentina R Garbarino; T Lee Gilman; Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Res       Date:  2018-07-24       Impact factor: 7.658

4.  Molecular biology research in neuropsychiatry: India's contribution.

Authors:  T S Sathyanarayana Rao; B N Ramesh; P Vasudevaraju; K S J Rao
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

5.  Family- and population-based designs identify different rare causal variants.

Authors:  Xue Zhang; Hua He; Lili Ding; Tesfaye M Baye; Brad G Kurowski; Lisa J Martin
Journal:  BMC Proc       Date:  2011-11-29

6.  Serotonin transporter functional polymorphisms potentially increase risk of schizophrenia separately and as a haplotype.

Authors:  Rana Ghamari; Fatemeh Yazarlou; Zahra Khosravizadeh; Atefeh Moradkhani; Elaheh Abdollahi; Fatemeh Alizadeh
Journal:  Sci Rep       Date:  2022-01-25       Impact factor: 4.379

7.  A systematic review of common genetic variation and biological pathways in autism spectrum disorder.

Authors:  Diego Alejandro Rodriguez-Gomez; Danna Paola Garcia-Guaqueta; Jesús David Charry-Sánchez; Elias Sarquis-Buitrago; Mariana Blanco; Alberto Velez-van-Meerbeke; Claudia Talero-Gutiérrez
Journal:  BMC Neurosci       Date:  2021-10-09       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.